Celsion Presents Preclinical Data For Its TheraSilence Platform At The miRNA World Conference Workshop On miRNA Delivery

By: via Benzinga
Celsion Corporation (NASDAQ: CLSN) today announced the presentation of data related to TheraSilence™, the Company's lung-specific RNA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.